Physician profile
Fuad Rafidi
NPI 1174639074
$4,020.86
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,337 · 2020: $200 · 2021: $669 · 2022: $998 · 2023: $773 · 2024: $43.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,010.15 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Boston Scientific Corporation | $626.26 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $588.88 | 2019-2023 | Xarelto |
| Medtronic, INC. | $253.84 | 2021-2023 | Abre, Closurefast, In.Pact Admiral |
| Amgen INC. | $252.79 | 2019 | |
| Pfizer INC. | $249.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $203.84 | 2019-2022 | |
| Inari Medical, INC. | $186.54 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $172.88 | 2022-2023 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm |
| Terumo Medical Corporation | $112.58 | 2020-2021 | |
| Medtronic Vascular, INC. | $110.09 | 2019-2020 | |
| Resmed Corp | $65.11 | 2022 | |
| Abbott Laboratories | $51.66 | 2019-2022 | |
| Cordis US Corp. | $43.93 | 2024 | Precise Pro Rx |
| Lilly USA, LLC | $24.45 | 2023 | Taltz |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $19.69 | 2022 | |
| Kci USA, INC. | $17.17 | 2022 | |
| Getinge USA Sales, LLC | $16.76 | 2020 | |
| Venclose INC. | $14.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fuad Rafidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.